anchor diagnostics
ANCHOR Diagnostics GmbH is a Hamburg, Germany-based molecular diagnostics company developing high-speed PCR test kits and extraction reagents for infectious disease detection, serving clinical and research laboratories across Europe, Latin America, and the Middle East through a network of regional distribution partners.
- Company typePrivate
- Founded2015
- HeadquartersHamburg, Germany
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What anchor diagnostics does
ANCHOR Diagnostics GmbH is a Hamburg, Germany-based molecular diagnostics company founded in 2015 that develops, manufactures, and distributes high-speed real-time PCR (polymerase chain reaction) test systems for infectious disease detection. The company's integrated workflow combines the ANCHOR BEAD 32 sample purification instrument and SpeedPURE reagents with a broad portfolio of CE-IVD-marked and RUO PCR kits covering herpesviruses (CMV, EBV, HSV 1/2, VZV, HHV-6/7/8), polyomaviruses (BK/JC), respiratory pathogens (Influenza A/B, SARS-CoV-2, viral respiratory multiplex), gastrointestinal pathogens (Norovirus, C. difficile), Monkeypox/Orthopoxvirus, and the emerging OROV arbovirus. The core technical proposition is a sub-60-minute sample-to-result workflow with PCR run times as short as 30 minutes, enabled by proprietary chemistry using distinguishable fluorescent dyes for parallel multi-target detection, integrated internal controls, and harmonized temperature profiles across all kits that allow seamless operation on standard laboratory cycler platforms (e.g., Roche MagNA Pure 96, cobas z480).
The company operates as a private GmbH with 11–50 employees and holds ISO 13485 certification for its quality management system. It generates revenue primarily through the sale of PCR kits (typically sold in 100-reaction kit formats) at quote-based unit pricing, supplemented by contract development services for custom molecular diagnostic solutions. The go-to-market model relies on a growing network of regional distribution partners across Europe (Italy, Poland, Nordics, UK & Ireland, Czech Republic, Greece, Benelux), Latin America (Colombia), the Middle East (Saudi Arabia), and Türkiye, complemented by direct quote handling via the company website and selective field sales engagement. Marketing efforts emphasize scientific credibility through LinkedIn, downloadable whitepapers, technical documentation, and participation in major industry conferences such as ESCMID.
ANCHOR Diagnostics' target customers are clinical diagnostic laboratories, research laboratories, and healthcare providers requiring rapid, reliable molecular testing for infectious disease management. The BSFZ Seal for Research and Development from the German Federal Ministry of Education and Research (awarded September 2025) and the November 2025 cross-laboratory validation study with MVZ Labor 28 (Berlin) reinforce the company's positioning on analytical rigor and scientific validation. The company is led by Thomas Grewing (legal representative) and Dr. Tobias Ruckes (Head of Sales & Marketing), with Ellen Knabbe serving as a Scientist contributing to product development. No external institutional funding rounds or acquisition activity are recorded in the available data, suggesting organic, founder-led growth.
anchor diagnostics firmographics
Firmographics- Name
- anchor diagnostics
- Legal name
- ANCHOR Diagnostics GmbH
- Website
- https://anchor-diagnostics.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ANCHOR Diagnostics GmbH is a Hamburg, Germany-based molecular diagnostics company developing high-speed PCR test kits and extraction reagents for infectious disease detection, serving clinical and research laboratories across Europe, Latin America, and the Middle East through a network of regional distribution partners.
- Ownership category
- akta.pro rank
anchor diagnostics industry classification
Industry- Product category
- Molecular Diagnostics / In Vitro Diagnostics
- NAICS
- Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)
- akta.pro secondary industries
- Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Molecular POCT / NAAT Systems (PCR/Isothermal platforms & cartridges) (HLAHAOAI), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)
Keywords
Where anchor diagnostics is headquartered
LocationHeadquarters
- HQ city
- Hamburg
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
anchor diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- PCR Diagnostic Kit Sales: ANCHOR Diagnostics generates revenue primarily through the sale of its molecular diagnostic PCR kits, including both CE-IVD (in vitro diagnostic) and RUO (research use only) products. Kits are sold in reaction sizes (e.g., 100 reactions per kit) and include master mix vials, positive and negative controls.
- Contract Development Services: The company offers contract development services for molecular diagnostics, including new diagnostic solution development, optimization or evaluation of existing products, and quality control and production support, providing tailored solutions to partners and customers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard reaction-based pricing for ANCHOR PCR kits (100-reaction kit format) |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
anchor diagnostics product offering
Product offeringCore offering
ANCHOR Diagnostics designs, produces, and distributes high-speed molecular PCR diagnostic test systems for infectious disease detection. The portfolio combines ANCHOR BEAD 32 and SpeedPURE reagents for rapid nucleic acid extraction with a broad suite of CE-IVD and RUO ANCHOR PCR Kits covering pathogens such as CMV, EBV, HSV, VZV, BK/JC, Norovirus, C. difficile, Monkey-/Orthopoxvirus, Influenza, SARS-CoV-2, and OROV, delivering PCR results in as fast as 30 minutes. The company also offers tailored contract development services for molecular diagnostic partners.
Product overview
ANCHOR Diagnostics offers a unified molecular diagnostics portfolio centered on high-speed PCR technology delivering results in under 60 minutes including nucleic acid extraction and PCR. The product ecosystem combines the ANCHOR BEAD 32 and SpeedPURE Reagents for rapid sample purification, paired with an extensive suite of ANCHOR PCR Kits covering infectious disease targets including herpesviruses (CMV, EBV, HSV 1/2, VZV, HHV-6/7/8), polyomaviruses (BK/JC), respiratory pathogens (Influenza A/B, SARS-CoV-2, Viral Respiratory panel), gastrointestinal pathogens (Norovirus, C. difficile), emerging arboviruses (OROV), and orthopoxviruses. Most products are CE-IVD marked for clinical diagnostic use, with some available as Research Use Only (RUO). The company also provides contract development services for custom molecular diagnostic solutions. All products are designed for compatibility with standard laboratory workflows and real-time PCR platforms.
Differentiator
Problem solved
Functional benefit
Brands
- ANCHOR BEAD 32: Sample purification product for nucleic acid extraction workflow
- SpeedPURE
- ANCHOR PCR Kits
- ANCHOR OROV PCR Kit
- ANCHOR CMV PCR Kit
Products and services
- ANCHOR BEAD 32 Sample purification system for rapid nucleic acid extraction, designed as part of the under-60-minute molecular workflow to enable high-speed processing for molecular diagnostics in clinical and research laboratories.
- SpeedPURE Reagents Reagent system for rapid nucleic acid purification designed to integrate with the ANCHOR BEAD 32 sample purification workflow for streamlined molecular diagnostics.
- ANCHOR CMV PCR Kit Quantitative or qualitative real-time PCR kit (CE-IVD) for amplification, detection, and quantitation of Cytomegalovirus (CMV) DNA from human EDTA plasma specimens, with a PCR run time of 30 minutes and dual-channel detection.
- ANCHOR EBV PCR Kit Real-time PCR-based test for detection of Epstein-Barr Virus (EBV) DNA from clinical specimens for use in clinical and research laboratories.
- ANCHOR HSV 1/2 PCR Kit Real-time PCR-based test for detection and differentiation of Herpes Simplex Virus types 1 and 2 (HSV 1/2) from clinical specimens.
- ANCHOR VZV PCR Kit Real-time PCR-based test for detection of Varicella-Zoster Virus (VZV) DNA from clinical specimens.
- ANCHOR HHV-6/7/8 Multiplex PCR Kit Multiplex real-time PCR assay for simultaneous detection of Human Herpesvirus types 6, 7, and 8 from clinical specimens.
- ANCHOR BK/JC Virus PCR Kit Real-time PCR-based test for detection of BK virus and JC virus DNA from clinical specimens.
- ANCHOR Viral Respiratory Multiplex PCR Kit Multiplex real-time PCR assay for simultaneous detection of multiple respiratory viruses from clinical specimens.
- ANCHOR Inf A/B + SARS-2 PCR Kit Multiplex real-time PCR assay for simultaneous detection of Influenza A, Influenza B, and SARS-CoV-2 from clinical specimens.
- ANCHOR Influenza A/B PCR Kit Real-time PCR-based test for detection and differentiation of Influenza A and Influenza B viruses from clinical specimens.
- ANCHOR SARS-CoV-2 PCR Kit v 2.0 Real-time PCR assay for detection of SARS-CoV-2 (COVID-19) viral RNA from clinical specimens, version 2.0 formulation.
- ANCHOR Norovirus PCR Kit Real-time PCR-based test (CE-IVD) for precise amplification, detection, and differentiation of Norovirus genogroup I (GI) and genogroup II (GII) RNA with internal control across three detector channels.
- ANCHOR C. difficile PCR Kit Real-time PCR-based test (CE-IVD) for precise amplification and detection of toxigenic Clostridioides difficile DNA, specifically detecting Toxin A (tcdA) and Toxin B (tcdB) genes without differentiation, across two detector channels.
- ANCHOR Monkey-/Orthopoxvirus PCR Kit Real-time PCR-based test (RUO) for amplification, detection, and differentiation of Monkeypox virus DNA and other Orthopoxvirus genus members including Modified-Vaccinia-Ankara (MVA) vaccine strain, supporting clade I and II strain detection across three detector channels.
- ANCHOR OROV PCR Kit Real-time RT-PCR-based assay (RUO) for reverse transcription, amplification, and qualitative detection of Oropouche virus (OROV) RNA targeting the S-segment of the viral genome.
- Contract Development Services Tailored contract development services for molecular diagnostics, including new diagnostic solution development, optimization or evaluation of existing products, quality control support, and production assistance for partners and customers.
Quantifiable outcome
- Complete molecular workflow (extraction to result) in under 60 minutes, with PCR run times as fast as 30 minutes
- +3 more outcomes
Companies that use anchor diagnostics
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
anchor diagnostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature8 records
anchor diagnostics partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core.
- ImogenacoreANCHOR Diagnostics expanded its Benelux region presence through Imogena, bringing rapid molecular workflows closer to laboratories across Belgium, the Netherlands, and Luxembourg. Imogena provides local distribution and technical support to clinical and research laboratories in the Benelux countries.
- SVEN BiolabscoreANCHOR Diagnostics expanded its Central Europe presence through a distribution partnership with SVEN Biolabs in the Czech Republic. SVEN Biolabs provides local distribution and technical support for ANCHOR's molecular diagnostic portfolio in the Czech market, supporting the company's broader European expansion strategy.
- Sartron BiotechnologycoreANCHOR Diagnostics partnered with Sartron Biotechnology to expand molecular diagnostics access in Türkiye. Sartron Biotechnology provides local market expertise and distribution support for ANCHOR's molecular diagnostic portfolio in the Turkish market as part of the company's global expansion.
- VARELAS S.A.coreANCHOR Diagnostics expanded its distribution network into Greece through a new partnership with VARELAS S.A. The partnership enables Greek laboratories to access ANCHOR's rapid molecular diagnostic solutions with local distribution and support.
- DSC ServicescoreANCHOR Diagnostics signed a strategic distribution agreement with DSC Services, making DSC Services the official distribution partner for Colombia. DSC Services is a trusted provider of diagnostic technologies and laboratory support services in Colombia, with established relationships with clinical, research, and reference laboratories. The partnership strengthens ANCHOR's presence in Latin America and expands access to its molecular diagnostic portfolio across the region.
- ImogenacoreANCHOR Diagnostics partnered with Imogena, a well-established distributor of life science and diagnostic solutions in Poland. Imogena is recognized for its strong engagement with clinical, research, and laboratory environments. This partnership enables Polish laboratories to access ANCHOR's 30-minute PCR diagnostic solutions with local technical support tailored to laboratory-specific requirements.
- ResnovacoreANCHOR Diagnostics expanded into the Italian market through a partnership with Resnova, a leading provider of diagnostic and laboratory solutions in Italy. Resnova is known for its close relationships with laboratories and application-focused approach. The partnership covers Italy, San Marino, Vatican State, and the Italian-speaking part of Switzerland, providing local distribution and hands-on market support for ANCHOR's 30-minute PCR diagnostics.
- XboXLabcoreANCHOR Diagnostics entered a strategic distribution partnership with XboXLab to strengthen molecular diagnostics support in the Nordic region, specifically Sweden, Norway, and Finland. Founded in Sweden in 2016, XboXLab has established itself as a technically focused distributor with strong laboratory connections throughout the Nordic region. The partnership enables Nordic laboratories to access ANCHOR's rapid PCR portfolio with local technical expertise.
- Max CarecoreANCHOR Diagnostics partnered with Max Care, a leading distributor of medical devices and equipment in Saudi Arabia, to strengthen its presence in the Middle East region. Founded in 2017, Max Care draws on more than 25 years of collective healthcare experience and operates across more than 20 countries, supporting hospitals and laboratories with access to advanced technologies.
- Stratech LtdcoreANCHOR Diagnostics entered into an exclusive distribution partnership with Stratech Ltd for the UK and Ireland market. Founded in 1983, Stratech is a leading provider of life science reagents and diagnostic tools with over 40 years of experience in the region. Stratech provides local distribution, logistics infrastructure, and trusted relationships with clinical, academic, and diagnostic institutions across the UK and Ireland.
Scale indicators5 records
Recent moves3 records
anchor diagnostics competitors and assessment
Company assessmentDirect peers
- ELITechGroup: European molecular diagnostics specialist with a portfolio of PCR kits (e.g., for HSV, CMV, EBV, BK virus) targeting routine clinical and reference laboratories. Closely comparable in size, menu focus, and CE-IVD positioning.
- Meridian Bioscience: Mid-cap IVD company specializing in molecular and immunoassay kits for infectious diseases, including PCR kits for C. difficile, respiratory, and GI pathogens. Comparable in size, product portfolio, and CE-IVD kit-led business model.
- Fast Track Diagnostics (Siemens Healthineers): Develops and commercializes a broad portfolio of CE-IVD real-time PCR kits for infectious disease diagnostics, directly overlapping with ANCHOR's herpesvirus, respiratory, and GI menus. Acquired by Siemens Healthineers, but historically a mid-cap kit-focused peer.
- Seegene: Korean molecular diagnostics company specializing in multiplex real-time PCR assays for infectious diseases, with a similar multiplex-channel differentiation approach. Comparable by product strategy (multiplex syndromic panels) and core technology.
- Altona Diagnostics: Hamburg-based molecular diagnostics company of comparable size, also developing and distributing real-time PCR kits for infectious disease detection (e.g., dengue, chikungunya, SARS-CoV-2). Most direct comparable by geography, product type, and target customer.
Broad incumbents
- Roche Diagnostics: Dominant clinical diagnostics player with cobas PCR systems (e.g., cobas z480 referenced in ANCHOR's cross-lab study) and a broad infectious disease menu. ANCHOR's cycler compatibility is intentionally aligned with Roche platforms, making Roche both a partner-platform and a competitive incumbent.
- Hologic: Molecular diagnostics player with the Panther system and Aptima assays for infectious disease testing. Comparable in infectious-disease menu (especially women's health and respiratory) and CE-IVD positioning.
- Cepheid (Danaher): Pioneer in rapid molecular diagnostics with the GeneXpert system delivering PCR results in ~30 minutes. Sets the speed benchmark ANCHOR aspires to and operates in the same hospital/lab segment.
- bioMérieux: Major IVD company with BIOFIRE FilmArray panels and conventional PCR-based ARGENE / NucliSENS kits covering infectious diseases. Overlaps with ANCHOR's respiratory and GI PCR kits but competes primarily with integrated instrument-panel systems.
- Qiagen: Global leader in sample-prep (e.g., QIAamp) and PCR-based kits (artisanal QIAstat-Dx, QuantiFERON). Overlaps with ANCHOR's BEAD 32 / SpeedPURE extraction line and PCR kit portfolio, but operates at much larger scale with FDA-cleared instruments.
Market position
Strengths5 records
Weaknesses5 records
Key risks7 records
Key highlights7 records
Customer concentration
anchor diagnostics social profiles
Digital presenceanchor diagnostics compliance and trust
Trust signalCompliance2 records
anchor diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
anchor diagnostics leadership team
Management profileNumber of profiles
Profiles3 records
anchor diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
anchor diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about anchor diagnostics
What does anchor diagnostics do?
ANCHOR Diagnostics designs, produces, and distributes high-speed molecular PCR diagnostic test systems for infectious disease detection. The portfolio combines ANCHOR BEAD 32 and SpeedPURE reagents for rapid nucleic acid extraction with a broad suite of CE-IVD and RUO ANCHOR PCR Kits covering pathogens such as CMV, EBV, HSV, VZV, BK/JC, Norovirus, C. difficile, Monkey-/Orthopoxvirus, Influenza, SARS-CoV-2, and OROV, delivering PCR results in as fast as 30 minutes. The company also offers tailored contract development services for molecular diagnostic partners.
Is anchor diagnostics a public or private company?
anchor diagnostics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was anchor diagnostics founded?
anchor diagnostics was founded in 2015. It employs 11 to 50 people.
Where is anchor diagnostics based?
anchor diagnostics is headquartered in Hamburg, Germany, in the Europe region.
How does anchor diagnostics make money?
Two revenue lines are on record. PCR Diagnostic Kit Sales are the primary driver. The others are contract Development Services.
Who are anchor diagnostics's main competitors?
Direct peers on record are ELITechGroup, Meridian Bioscience, Fast Track Diagnostics (Siemens Healthineers), Seegene and Altona Diagnostics. Broad incumbents are Roche Diagnostics, Hologic, Cepheid (Danaher), bioMérieux and Qiagen.
Does anchor diagnostics have an API?
No public API is recorded for anchor diagnostics.
What industry is anchor diagnostics in?
anchor diagnostics's product category is Molecular Diagnostics / In Vitro Diagnostics. Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays). Its NAICS code is 62151 and its SIC code is 2835.